Psychopharmacotherapy for Depressive Patients

Recruiting N/A Interventional Study
Major Depressive Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
400 (estimated)
Sponsor
Chonnam National University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The primary purpose of this study is to compare the short (12 week) and long-term (1-year) efficacy and the tolerability between stepwise psychopharmacotherapy and antidepressant monotherapy for 12 weeks in adult patients with major depressive disorders, stratified by the multimodal serum biomarker scores.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 19 to 65 years * Diagnostic and Statistical Manual of Mental Disorders-IV criteria for major depressive disorder by study psychiatrists * Score≥17 on Hamilton Depression Rating Scale-17 * With ability to understand the objective of the study and sign informed consent * Initiat…
Contacts

Jae-Min Kim, MD, PhD

82-62-220-6043

jmkim@chonnam.ac.kr

CONTACT

Hee-Ju Kang, MD, PhD

82-62-220-5961

hjkang82@chonnam.ac.kr

CONTACT